Haruhito Totani1, Shigeru Kusumoto1, Kentaro Yonekura2, Nobuaki Nakano3, Asahi Ito1, Ilseung Choi4, Yoshitaka Imaizumi5, Makoto Yoshimitsu6, Kisato Nosaka7, Michihiro Hidaka8, Tatsuro Jo9, Hidenori Sasaki10, Yukiyoshi Moriuchi11, Yoko Suehiro4, Ryuzo Ueda12, Atae Utsunomiya3, Takashi Ishida1 (1.Dept. Hematol & Oncol., Nagoya City Univ., Nagoya, Japan, 2.Dept. Dermatol., Imamura General Hosp., Kagoshima, Japan, 3.Dept. Hematol., Imamura General Hosp., Kagoshima, Japan, 4.Dept. Hematol., Kyushu Cancer Ctr. Hosp., Fukuoka, Japan, 5.Dept. Hematol., Nagasaki Univ. Hosp., 6.Dept. Hematol & Immunol., Kagoshima Univ. Hosp., Kagoshima, Japan, 7.Dept. Hematol., Kumamoto Univ Hosp., Kumamoto, Japan, 8.Dept. Hematol&Inst. for Clin. Res., Kumamoto Med Ctr., Kumamoto, Japan, 9.Dept. Hematol., Jpn Red Cross Nagasaki Genbaku Hosp., Nagasaki, Japan, 10.Div. Med Oncol, Hematol&Infect Diseases, Fukuoka Univ Hosp., Fukuoka, Japan, 11.Dept. Hematol., Sasebo City General Hosp., Sasebo, Japan, 12.Dept. Tumor Immunol., Aichi Med Univ., Nagakute, Japan)
Session information
Oral Session
Oral Session 2-8A Viral Infection
Sat. Oct 12, 2019 9:00 AM - 10:10 AM No.8 (Tokyo International Forum, 1F Hall D1)
Chair: Hiromichi Iwasaki (Dep of Infect Control Prevent, University of Fukui)
Takayuki Sato, Kenki Saito, Kaori Fujimura, Tomoko Imanaka, Hiroki Hayata, Atsushi Ueda, Ryosuke Takaya, Kazuya Okada, Takeshi Maeda, Tatsuhito Onishi, Yasunori Ueda (Haematol./Oncol., Kurashiki Central Hospital, Kurashiki, Japan)
Yoshikazu Ikoma1, Yuhei Shibata1, Naoe Goto1, Senji Kasahara2, Takafumi Naiki2, Hisashi Tsurumi3, Takeshi Takahashi1 (1.Dept. Hematol., Gifu Muni. Hosp., Gifu, Japan, 2.Dept. Clin. Lab. Gifu Muni. Hosp., Gifu, Japan, 3.Dept. Hematol., Matsunami Gen. Hosp., Gifu, Japan)
Koji Kawamura1, Hideki Nakasone1, Yu Akahoshi1, Shunto Kawamura1, Junko Takeshita1, Nozomu Yoshino1, Yukiko Misaki1, Kazuki Yoshimura1, Ayumi Gomyo1, Masaharu Tamaki1, Machiko Kusuda1, Kazuaki Kameda1, Hidenori Wada1, Miki Sato1, Kiriko Saito1, Aki Tanihara1, Shunichi Kimura1, Shinichi Kako1, Yoshinobu Kanda1,2 (1.Division of Hematology, Jichi Medical University Saitama Medical Center, 2.Division of Hematology, Jichi Medical University)
Shintaro Izumi, Yoshikazu Utsu, Akihiro Nakajima, Rei Kato, Yasuhito Hatanaka, Ayako Nakamura, Hironori Arai, Shinichi Masuda, Reiko Nakaseko, Nobuyuki Aotsuka (Hemato Oncol., Japanese Red Cross Narita Hospital, Chiba, Japan)
Koji Kawamura1, Hideki Nakasone1, Hidenori Wada1, Yu Akahoshi1, Shunto Kawamura1, Junko Takeshita1, Nozomu Yoshino1, Yukiko Misaki1, Kazuki Yoshimura1, Ayumi Gomyo1, Masaharu Tamaki1, Machiko Kusuda1, Kazuaki Kameda1, Miki Sato1, Kiriko Saito1, Aki Tanihara1, Shunichi Kimura1, Shinichi Kako1, Yoshinobu Kanda1,2 (1.Division of Hematology, Jichi Medical University Saitama Medical Center, 2.Division of Hematology, Jichi Medical University)
Yuki Mori1, Mitsuhiro Yuasa1, Daisuke Kaji1, Kosei Kageyama1, Aya Nishida1, Shinsuke Takagi1, Hisashi Yamamoto1, Kazuya Ishiwata2, Go Yamamoto1, Atsushi Wake2, Naoyuki Uchida1, Shuichi Taniguchi1 (1.Department of Hematology, Toranomon Hospital, Tokyo, Japan, 2.Department of Hematology, Toranomon Hospital Kajigaya, Kanagawa, Japan)